Drug Discovery Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

The global drug discovery market is projected to grow from $33998 million in 2018 to $68684 million by 2024 growing at a CAGR of 9.20% during the forecast period.  Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology and pharmacology. It is a complicated, lengthy and expensive process. Though advanced technologies are available, the success rate of drug discovery is meagre and the time involved is relatively high.

Global Drugs Discovery Market Share:

Compared to the past years, Global Drugs Market has undergone a predominant change in the markets. Pharmaceutical Services is expected to have the highest growth rate when compared with other segments.

Global Drugs Discovery Market Size:

Geographically, the global drug discovery outsourcing market can be categorised into North America, Europe, Asia-Pacific and rest of the world regions. North America currently holds the most significant share in this market and is followed by Europe due to the existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for drug discovery outsourcing and is expected to undergo rapid market growth.

Global Drugs Discovery Market Growth:

High prevalence of health disorders such as genetic disorders, nervous system disorders, diabetes, cardiovascular diseases and others; rising demand for novel drug discovery technologies owing to the growing population; and advancements in the field of biotechnology, molecular biology and genomics. Moreover, the populated pipeline for novel drugs coupled with the patent expiry of several other drugs and increased expenditure on healthcare is also driving the market growth.

Global Drugs Discovery Market Industry Analysis:

The drug discovery market by the technology is segmented into QPCR, DNA microarrays, protein microarrays, high-throughput screening, mass spectrometry, etc. By service, The market is segmented into Pharmaceutical Services, Drug Metabolism and Pharmacokinetics (DMPK) Services, etc. By End-users, The market is segmented into Biotech companies, Pharmaceutical companies, etc.

Global Drugs Discovery Market Outlook:

Massive investments, a shift of market branded drugs to generic drugs and delayed processing of government regulations are hampering the market growth. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America gains high-income population, collectively promising healthy potential returns on investments due to the high adoption rate of new technologies.

Global Drugs Discovery Market Trends:

Merck Receives an FDA Approval for ISENTRESS, in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection in Newborns Weighing at Least 2 kg. Jubilant Biosys Ltd. announced that they successfully achieved an early stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic disorders.

Global Drugs Discovery Market Research report includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by the analyst to the individual and organisation to have the better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Jubilant Biosys
• Roche Holding AG
• Sanofi
• Infosys
• Covance